Drug adherence in Multi-resistant Tuberculosis: an integrative review
DOI:
https://doi.org/10.33448/rsd-v11i5.28244Keywords:
Multidrug-resistant tuberculosis; Multiple drug resistant tuberculosis; Medication adherence.Abstract
Objective: Investigate non-adherence to the drug treatment for multidrug-resistant tuberculosis (MDR TB). Methodology: A literature searching was carried out in databases, Lilacs and Medline, using the following descriptors: ‘Tuberculose Resistente a Múltiplos Medicamentos’, ‘Tuberculose Multidroga Resistente’, ‘Tuberculose Farmacorresistente’, ‘Tuberculosis’, ‘Multidrug-Resistant’, ‘Tuberculosis Resistente a Múltiples Medicamentos’, ‘Adesão à Medicação’, ‘Adesão’, ‘Medication Adherence’ e ‘Cumplimiento de la Medicación’. The period selected for the research was December 2016 to December 2021. After applying the adopted criteria, 18 articles met the prerequisites for the analysis. Results: The treatment abandonment rate in TB is high and one of the main concerns for TB control is the reduction of this non-adherence to drug therapy. The factors that provide better treatment adherence are related to health care, TB control programs, in addition to the patients' desire to live. Conclusion: MDR TB is a major public health problem, requiring the application of several measures related to patient care by the multidisciplinary health team.
References
Alegria-Flores, K., Weiner, B. J., Wiesen, C. A., Lich, K. L. H., Van Rie, A., Paul, J. E., & Tovar, M. A. (2017). Innovative approach to the design and evaluation of treatment adherence interventions for drug-resistant TB. The International Journal of Tuberculosis and Lung Disease, 21(11), 1160–1166. doi:10.5588/ijtld.17.0296
Arnold, A., Cooke, G. S., Kon, O. M., Dedicoat, M., Lipman, M., Loyse, A., … Harrison, T. S. (2017). Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008–2014. Journal of Infection, 74(3), 260–271. doi:10.1016/j.jinf.2016.12.005
Batte, C., Namusobya, M.S., Kirabo, R., Mukisa J., Adakun, S. & Katamba, A. (2021). Prevalence and factors associated with nonadherence
to multi-drug resistant tuberculosis (MDR-TB) treatment at Mulago National Referral Hospital, Kampala, Uganda. Afri Health Sci.; 21(1):238-47. doi:10.4314/ahs.v21i1.31
Bionghi, N., Daftary, A., Maharaj, B., Msibi, Z., Amico, K.R., Friendland, G., ... O’Donnell, M.R. (2018). Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa. BMC Infect Dis. 18, 171. doi:10.1186/s12879-018-3080-2
BRASIL. (2018). Ministério da Saúde. Implantação do Plano Nacional pelo Fim da Tuberculose como Problema de Saúde Pública no Brasil: primeiros passos rumo ao alcance das metas. Boletim Epidemiológico [Internet]. 49(11):1-18. http://portalarquivos2.saude.gov.br/images/pdf/2018/marco/26/2018-009.pdf.
BRASIL. (2019). Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Manual de Recomendações para o Controle da Tuberculose no Brasil / Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis (2ª ed.) Brasília/DF.
BRASIL. (2021). Ministério da Saúde. Secretaria de Vigilância em Saúde. Tuberculose 2021. Boletim Epidemiológico Especial, Brasília, número especial. Recuperado de: http://www.aids.gov.br/pt-br/pub/2021/boletim-tuberculose-2021.
Caminero, J.A, Scardigli, A., van der Werf, T. & Tadolini, M. (2018). Treatment of drug-susceptible and drug-resistant tuberculosis. In: Miogliori, G.B., Bothaley, G., Duarte, R. et al, eds. Tuberculosis [ERS monograph]. Sheffield, European Respiratory Society, 2018; pp. 152-178. doi: 10.1183/2312508X.10021417.
Daftary, A., Mondal, S., Zelnick, J., Friedland,G., Seepamore, B., Boodhram, R., ... Max R O’Donnell. (2021). Dynamic needs and challenges of people with drug-resistant tuberculosis and HIV in South Africa: a qualitative study. Lancet Glob Health; 9: e479–88. doi: 10.1016/S2214-109X(20)30548-9
Deshmukh, R. D., Dhande, D. J., Sachdeva, K. S., Sreenivas, A. N., Kumar, A. M. V., & Parmar, M. (2018). Social support a key factor for adherence to multidrug-resistant tuberculosis treatment. Indian Journal of Tuberculosis, 65(1), 41–47. doi:10.1016/j.ijtb.2017.05.003
Ferreira, D.P, Souza, F.B.A. & Motta, M.C.S. (2019) Abandono de tratamento anterior e caso de tuberculose multidroga resistente em uma instituição terciária na cidade do Rio de Janeiro. Rev Fun Care Online. 11(4):962-967. doi: 10.9789/2175-5361.2019.v11i4.962-967
Ferreira, K.R., Orlandi, G.M., Silva, T.C., Bertolozzi, M.R., França, F.O.S. & Bender, A. (2018) Representations on adherence to the treatment of Multidrug-Resistant Tuberculosis. Rev Esc Enferm USP. 52:e03412. doi:10.1590/S1980-220X2018010303412
Galvão, T.F., Pansani, T.S.A. & Harrad, D. (2015). Principais itens para relatar Revisões sistemáticas e Meta-análises: A recomendação PRISMA. Epidemiol. Serv. Saúde. 24(2):335-342. doi: 10.5123/S1679-49742015000200017
Germano, S.N.F., Esteves, A.V.F. & Garrido, M.S. (2021). Tuberculose drogarresistente, orientações e acompanhamento pela atenção primária à saúde: revisão integrativa. REAS/EJCH, 13(1), e5867. doi:10.25248/reas.e5867.2021
Kidenya, B. R., Mshana, S. E., Gerwing-Adima, L., Kidola, J., & Kasang, C. (2017). Drug adherence and efficacy of smear microscopy in the diagnosis of pulmonary tuberculosis after 2 months of medication in North-western Tanzania. International Journal of Infectious Diseases, 63, 43–47. doi:10.1016/j.ijid.2017.07.025
Kizito, E., Musaazi, J., Mutesasira, K., Twinomugisha, F., Namwanje, H., Kiyemba, T., ... Zawedde-Muyanja, S. (2021). Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study. BMC Infect Dis. 21, 292. doi:10.1186/s12879-021-05967-2
Khan, M.S., Hutchison, C., Coker, R.J., Yoong, J., Hane, K.M., Innes, A.L., ... Aung, S. (2017). Preventing emergence of drug resistant tuberculosis in Myanmar's transitioning health system. Health Policy and Planning. 32, Issue suppl_2, ii43–ii50, https://doi.org/10.1093/heapol/czx093
Liu, X., Blaschke, T., Thomas, B., De Geest, S., Jiang, S., Gao, Y., … Huan, S. (2017). Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis. International Journal of Environmental Research and Public Health, 14(10), 1115. doi:10.3390/ijerph14101115
Mukasa, J., Kayongo, E., Kawooya, I., Lukoye, D., Etwom, A., Mugabe, F., ... Mijumbi-Deve, R. (2020). Adherence to the MDR-TB intensive phase treatment protocol amongst individuals followed up at central and peripheral health care facilities in Uganda - a descriptive study. Afri Health Sci.; 20(2): 625-632. doi:10.4314/ahs.v20i2.10
Murphy, D. (2018). Multidrug resistant TB: fully oral regimens should help improve compliance, says WHO. BMJ. 362 :k3610 doi:10.1136/bmj.k3610
Okethwangu, D., Birungi, D., Biribawa, C., Kwesiga, B., Turyahabwe, S., Ario, A. R., & Zhu, B.-P. (2019). Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013–2017. BMC Infectious Diseases, 19 (1), 387. doi:10.1186/s12879-019-4014-3
Rivera, O., Benites, S., Mendigure, J. & Bonilla, C.A. (2019). Abandono del tratamiento en tuberculosis multirresistente: factores asociados en una región con alta carga de la enfermedad en Perú. Biomédica. 39 (Supl.2):44-57
Souza, M.T., Silva, M.D. & Carvalho, R. (2010). Revisão integrativa: o que é e como fazer. Einstein. 8(1 Pt 1):102-6
Thomas, B.E., Kumar, J.V., Periyasamy, M., Khandewale, A.S., Hephzibah Mercy, J., Raj, E.M., ... Subbaraman, R. (2021). Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers. J Med Internet Res. 23(6):e23294. doi: 10.2196/23294
Tola, H. H., Holakouie-Naieni, K., Mansournia, M. A., Yaseri, M., Tesfaye, E., Mahamed, Z. & Sisay, M. M. (2019). Intermittent treatment interruption and its effect on multidrug resistant tuberculosis treatment outcome in Ethiopia. Scientific Reports, 9(1). doi:10.1038/s41598-019-56553-1
Valença, I.M.O., Lima, M.C.L., Dourado, C.A.R.O., Andrade, M.S., Falcão, A.C.N.S., Pereira, W.M.S., ... Pinho, C.M. (2020). Perfil epidemiológico dos casos de tuberculose drogarresistente. REAS/EJCH, Vol.Sup.n.56, e4334, 2020. doi:10.25248/reas.e4334.2020
WHO, World Health Organization. (2017). Guidelines for the Treatment of Drug-Susceptible Tuberculosis and Patient Care. 2017 Update; WHO: Geneva, Switzerland; p. 25.
Yin, J., Wang, X., Zhou, L., & Wei, X. (2018). The relationship between social support, treatment interruption and treatment outcome in patients with multidrug-resistant tuberculosis in China: a mixed-methods study. Tropical Medicine & International Health, 23(6), 668–677. doi:10.1111/tmi.13066
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Raquel Ribeiro de Souza; Carlos Augusto Abreu Alberio
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
